288 related articles for article (PubMed ID: 17868461)
1. Inverse association of plasma IL-13 and inflammatory chemokines with lung function impairment in stable COPD: a cross-sectional cohort study.
Lee JS; Rosengart MR; Kondragunta V; Zhang Y; McMurray J; Branch RA; Choi AM; Sciurba FC
Respir Res; 2007 Sep; 8(1):64. PubMed ID: 17868461
[TBL] [Abstract][Full Text] [Related]
2. Plasma cytokine profiles related to smoking-sensitivity and phenotypes of chronic obstructive pulmonary disease.
Nakamura M; Nakamura H; Minematsu N; Chubachi S; Miyazaki M; Yoshida S; Tsuduki K; Shirahata T; Mashimo S; Takahashi S; Nakajima T; Tateno H; Fujishima S; Betsuyaku T
Biomarkers; 2014 Aug; 19(5):368-77. PubMed ID: 24842387
[TBL] [Abstract][Full Text] [Related]
3. Effects of inhaled HFA beclomethasone on pulmonary function and symptoms in patients with chronic obstructive pulmonary disease.
John M; Bosse S; Oltmanns U; Schumacher A; Witt C
Respir Med; 2005 Nov; 99(11):1418-24. PubMed ID: 15894479
[TBL] [Abstract][Full Text] [Related]
4. Plasma Chemokine signature correlates with lung goblet cell hyperplasia in smokers with and without chronic obstructive pulmonary disease.
Kim V; Cornwell WD; Oros M; Durra H; Criner GJ; Rogers TJ
BMC Pulm Med; 2015 Sep; 15():111. PubMed ID: 26424214
[TBL] [Abstract][Full Text] [Related]
5. Eosinophil and T cell markers predict functional decline in COPD patients.
D'Armiento JM; Scharf SM; Roth MD; Connett JE; Ghio A; Sternberg D; Goldin JG; Louis TA; Mao JT; O'Connor GT; Ramsdell JW; Ries AL; Schluger NW; Sciurba FC; Skeans MA; Voelker H; Walter RE; Wendt CH; Weinmann GG; Wise RA; Foronjy RF
Respir Res; 2009 Nov; 10(1):113. PubMed ID: 19925666
[TBL] [Abstract][Full Text] [Related]
6. Disproportionally Impaired Diffusion Capacity Relative to Airflow Limitation in COPD.
Tanabe N; Rhee CK; Sato S; Muro S; Shima H; Tanimura K; Jung KS; Yoo KH; Hirai T
COPD; 2020 Dec; 17(6):627-634. PubMed ID: 33222554
[TBL] [Abstract][Full Text] [Related]
7. The value of blood cytokines and chemokines in assessing COPD.
Bradford E; Jacobson S; Varasteh J; Comellas AP; Woodruff P; O'Neal W; DeMeo DL; Li X; Kim V; Cho M; Castaldi PJ; Hersh C; Silverman EK; Crapo JD; Kechris K; Bowler RP
Respir Res; 2017 Oct; 18(1):180. PubMed ID: 29065892
[TBL] [Abstract][Full Text] [Related]
8. Identification of COPD Patients at High Risk for Lung Cancer Mortality Using the COPD-LUCSS-DLCO.
de-Torres JP; Marín JM; Casanova C; Pinto-Plata V; Divo M; Cote C; Celli BR; Zulueta JJ
Chest; 2016 Apr; 149(4):936-42. PubMed ID: 26513409
[TBL] [Abstract][Full Text] [Related]
9. Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: a network approach.
de Llano LP; Cosío BG; Iglesias A; de Las Cuevas N; Soler-Cataluña JJ; Izquierdo JL; López-Campos JL; Calero C; Plaza V; Miravitlles M; Torrego A; Martinez-Moragon E; Soriano JB; Viña AL; Bobolea I
Int J Chron Obstruct Pulmon Dis; 2018; 13():591-601. PubMed ID: 29483774
[TBL] [Abstract][Full Text] [Related]
10. Diffusion capacity of the lung for carbon monoxide - A potential marker of impaired gas exchange or of systemic deconditioning in chronic obstructive lung disease?
Weinreich UM; Thomsen LP; Brock C; Karbing DS; Rees SE
Chron Respir Dis; 2015 Nov; 12(4):357-64. PubMed ID: 26323278
[TBL] [Abstract][Full Text] [Related]
11. Serum IL-1β and IL-17 levels in patients with COPD: associations with clinical parameters.
Zou Y; Chen X; Liu J; Zhou DB; Kuang X; Xiao J; Yu Q; Lu X; Li W; Xie B; Chen Q
Int J Chron Obstruct Pulmon Dis; 2017; 12():1247-1254. PubMed ID: 28490868
[TBL] [Abstract][Full Text] [Related]
12. Serum cytokine profiling and enrichment analysis reveal the involvement of immunological and inflammatory pathways in stable patients with chronic obstructive pulmonary disease.
Bade G; Khan MA; Srivastava AK; Khare P; Solaiappan KK; Guleria R; Palaniyar N; Talwar A
Int J Chron Obstruct Pulmon Dis; 2014; 9():759-73. PubMed ID: 25125975
[TBL] [Abstract][Full Text] [Related]
13. Combined effects of lung function, blood gases and kidney function on the exacerbation risk in stable COPD: Results from the COSYCONET cohort.
Trudzinski FC; Kahnert K; Vogelmeier CF; Alter P; Seiler F; Fähndrich S; Watz H; Welte T; Speer T; Zewinger S; Biertz F; Kauczor HU; Jörres RA; Bals R;
Respir Med; 2019; 154():18-26. PubMed ID: 31203096
[TBL] [Abstract][Full Text] [Related]
14. Diffusing Capacity of Carbon Monoxide in Assessment of COPD.
Balasubramanian A; MacIntyre NR; Henderson RJ; Jensen RL; Kinney G; Stringer WW; Hersh CP; Bowler RP; Casaburi R; Han MK; Porszasz J; Barr RG; Make BJ; Wise RA; McCormack MC
Chest; 2019 Dec; 156(6):1111-1119. PubMed ID: 31352035
[TBL] [Abstract][Full Text] [Related]
15. Tidal expiratory flow limitation at rest as a functional marker of pulmonary emphysema in moderate-to-severe COPD.
Chiari S; Bassini S; Braghini A; Corda L; Boni E; Tantucci C
COPD; 2014 Feb; 11(1):33-8. PubMed ID: 24102405
[TBL] [Abstract][Full Text] [Related]
16. Lower leptin/adiponectin ratio and risk of rapid lung function decline in chronic obstructive pulmonary disease.
Suzuki M; Makita H; Östling J; Thomsen LH; Konno S; Nagai K; Shimizu K; Pedersen JH; Ashraf H; Bruijnzeel PL; Maciewicz RA; Nishimura M; ;
Ann Am Thorac Soc; 2014 Dec; 11(10):1511-9. PubMed ID: 25372271
[TBL] [Abstract][Full Text] [Related]
17. Correlation between serum biomarkers and BODE index in patients with stable COPD.
Liu SF; Chin CH; Wang CC; Lin MC
Respirology; 2009 Sep; 14(7):999-1004. PubMed ID: 19740260
[TBL] [Abstract][Full Text] [Related]
18. Plasma Inflammatory Cytokine IL-4, IL-8, IL-10, and TNF-α Levels Correlate with Pulmonary Function in Patients with Asthma-Chronic Obstructive Pulmonary Disease (COPD) Overlap Syndrome.
Huang AX; Lu LW; Liu WJ; Huang M
Med Sci Monit; 2016 Aug; 22():2800-8. PubMed ID: 27501772
[TBL] [Abstract][Full Text] [Related]
19. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].
Xin XF; Zhao M; Li ZL; Song Y; Shi Y
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998
[TBL] [Abstract][Full Text] [Related]
20. The effect of comorbidities on COPD assessment: a pilot study.
Weinreich UM; Thomsen LP; Bielaska B; Jensen VH; Vuust M; Rees SE
Int J Chron Obstruct Pulmon Dis; 2015; 10():429-38. PubMed ID: 25750525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
